These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24146103)

  • 1. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
    Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
    Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
    Wang M; Li X; Qu Y; Xu O; Sun Q
    Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.
    Xu YY; Wu TT; Zhou SH; Bao YY; Wang QY; Fan J; Huang YP
    Int J Clin Exp Pathol; 2014; 7(7):3938-47. PubMed ID: 25120770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
    Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
    Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1.
    Xu YY; Bao YY; Zhou SH; Fan J
    Arch Med Res; 2012 Jul; 43(5):395-401. PubMed ID: 22835601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT-1 siRNA Enhances Radiosensitization Of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, And Promotion Of Apoptosis In Vitro And In Vivo.
    Zhong JT; Yu Q; Zhou SH; Yu E; Bao YY; Lu ZJ; Fan J
    Onco Targets Ther; 2019; 12():9129-9142. PubMed ID: 31806998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
    Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
    Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1.
    Zhou SH; Fan J; Chen XM; Cheng KJ; Wang SQ
    Head Neck; 2009 Dec; 31(12):1624-33. PubMed ID: 19441091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
    Xi J; Wang Y; Liu H
    Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
    Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
    Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line.
    Qiu HO; Wang H; Che N; Li D; Mao Y; Zeng Q; Ge R
    Med Sci Monit; 2016 Apr; 22():1146-51. PubMed ID: 27049928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
    Wei XD; He J; Gao JX; Wang JY; Ma BJ; Chen J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):578-83. PubMed ID: 24313208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.